Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies
- 14 August 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 8 (12), 1861-1870
- https://doi.org/10.1517/14656566.8.12.1861
Abstract
Post-traumatic stress disorder (PTSD) is often a chronic and disabling anxiety disorder that develops after exposure to a traumatic event. Researchers have demonstrated efficacy for both pharmacologic and psychosocial interventions in the treatment of PTSD. First-line pharmacotherapeutic options are the selective serotonin re-uptake inhibitors and serotonin noradrenaline re-uptake inhibitors. Older antidepressant agents, such as the tricyclic antidepressants and the monoamine oxidase inhibitor, phenelzine, have also proven efficacy in PTSD among more established agents. However, concerns for side effects have limited frequent use of these. Existing pharmacologic agents produce meaningful results and bear the advantage of treating depression and other co-morbid disorders, yet still fall short of being ideal due to limited response and remission rates and tolerability issues. The need for improving pharmacotherapy of PTSD remains compelling and directions for further research are discussed.Keywords
This publication has 83 references indexed in Scilit:
- Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress DisorderJournal of Clinical Psychopharmacology, 2007
- Meeting everyday challenges: Antipsychotic therapy in the real worldEuropean Neuropsychopharmacology, 2006
- Effect of Sertraline on Glucocorticoid Sensitivity of Mononuclear Leukocytes in Post-Traumatic Stress DisorderNeuropsychopharmacology, 2005
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- Low-Dose Cortisol for Symptoms of Posttraumatic Stress DisorderAmerican Journal of Psychiatry, 2004
- Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in Posttraumatic Stress Disorder: A Double-Blind, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2004
- Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studiesExpert Opinion on Pharmacotherapy, 2003
- Antidepressant-induced hepatotoxicityExpert Opinion on Drug Safety, 2003
- Comorbidity, Impairment, and Suicidality in Subthreshold PTSDAmerican Journal of Psychiatry, 2001
- Inositol treatment of post-traumatic stress disorderAnxiety, 1996